Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Methylibium petroleiphilum Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C CSB-YP383537MNX
CSB-EP383537MNX
CSB-BP383537MNX
CSB-MP383537MNX
CSB-EP383537MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum ATP synthase subunit c (atpE), partial CSB-YP383538MNX1
CSB-EP383538MNX1
CSB-BP383538MNX1
CSB-MP383538MNX1
CSB-EP383538MNX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP383539MNX
CSB-EP383539MNX
CSB-BP383539MNX
CSB-MP383539MNX
CSB-EP383539MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Gamma-glutamyl phosphate reductase (proA) CSB-YP383540MNX
CSB-EP383540MNX
CSB-BP383540MNX
CSB-MP383540MNX
CSB-EP383540MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP383541MNX
CSB-EP383541MNX
CSB-BP383541MNX
CSB-MP383541MNX
CSB-EP383541MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP383542MNX
CSB-EP383542MNX
CSB-BP383542MNX
CSB-MP383542MNX
CSB-EP383542MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum D-alanine--D-alanine ligase (ddl) CSB-YP383543MNX
CSB-EP383543MNX
CSB-BP383543MNX
CSB-MP383543MNX
CSB-EP383543MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Glutamate 5-kinase (proB) CSB-YP383544MNX
CSB-EP383544MNX
CSB-BP383544MNX
CSB-MP383544MNX
CSB-EP383544MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum RNA pyrophosphohydrolase (rppH) CSB-YP383545MNX
CSB-EP383545MNX
CSB-BP383545MNX
CSB-MP383545MNX
CSB-EP383545MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum 8-amino-7-oxononanoate synthase (bioF) CSB-YP383546MNX
CSB-EP383546MNX
CSB-BP383546MNX
CSB-MP383546MNX
CSB-EP383546MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Bifunctional protein GlmU (glmU) CSB-YP383547MNX
CSB-EP383547MNX
CSB-BP383547MNX
CSB-MP383547MNX
CSB-EP383547MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Urease accessory protein UreG (ureG) CSB-YP383548MNX
CSB-EP383548MNX
CSB-BP383548MNX
CSB-MP383548MNX
CSB-EP383548MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Urease accessory protein UreE (ureE) CSB-YP383549MNX
CSB-EP383549MNX
CSB-BP383549MNX
CSB-MP383549MNX
CSB-EP383549MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Aspartate carbamoyltransferase (pyrB) CSB-YP383550MNX
CSB-EP383550MNX
CSB-BP383550MNX
CSB-MP383550MNX
CSB-EP383550MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Protein-export protein secB (secB) CSB-YP383551MNX
CSB-EP383551MNX
CSB-BP383551MNX
CSB-MP383551MNX
CSB-EP383551MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Imidazoleglycerol-phosphate dehydratase (hisB) CSB-YP383552MNX
CSB-EP383552MNX
CSB-BP383552MNX
CSB-MP383552MNX
CSB-EP383552MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Sec-independent protein translocase protein TatA (tatA), partial CSB-YP383553MNX
CSB-EP383553MNX
CSB-BP383553MNX
CSB-MP383553MNX
CSB-EP383553MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum Aspartate--tRNA ligase (aspS), partial CSB-YP383554MNX
CSB-EP383554MNX
CSB-BP383554MNX
CSB-MP383554MNX
CSB-EP383554MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum tRNA (guanine-N (1)-)-methyltransferase CSB-YP383555MNX
CSB-EP383555MNX
CSB-BP383555MNX
CSB-MP383555MNX
CSB-EP383555MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylibium petroleiphilum 50S ribosomal protein L33 (rpmG) CSB-YP383556MNX
CSB-EP383556MNX
CSB-BP383556MNX
CSB-MP383556MNX
CSB-EP383556MNX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>